You are here: Industry Insights > India

News List

Centre to come up with R&D policy for pharma sector: DoP Secretary expresspharma
August 06, 2020
He informed that the government is planning to set up three national CoEs for drugs, medical devices in the country and NIPER Hyderabad will house one CoE for drug discovery.
In the pharma industry, technology has become a mandate for some compliances expresspharma
August 05, 2020
The importance of information technology and its potential to enhance the life sciences industry’s performance has been accentuated by the COVID-19 crisis.
Policymakers to identify groups of people who will get priority for COVID-19 vaccine expresspharma
August 03, 2020
Four major challenges await India once a vaccine is available, i.e. prioritisation and fair distribution to vulnerable groups; logistics of vaccine rollout, including cold chain; stockpiling and training people who will administer this vaccine: ICMR Head.
Golden moment for India in key sectors including pharma over next 10 years: Venture capitalist expresspharma
July 20, 2020
Indian ministers, key bureaucrats and technology industry leaders should put together a roadmap, set of regulations and authorisations so that companies can come in easily, says Silicon Valley entrepreneur and investor, MR Rangaswami.
Indian pharma industry can produce COVID-19 vaccines for entire world: Bill Gates expresspharma
July 17, 2020
Highlighting Gates Foundation's role in India’s war against coronavirus, he said that it has been funding work on detection and isolation, especially in UP and Bihar.
Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy expresspharma
June 28, 2020
Companies investing in backward integration, new age technology, etc. would get the preference in the PLI scheme.
Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine expresspharma
June 24, 2020
In the recent past, many, globally and in India, had raised concerns about a potential shortage of ancillary supplies to distribute the vaccine, after development.
Nurses: A barrier between patients and counterfeit drugs expresspharma
June 04, 2020
With an increase in pharma companies, number and types of drugs for patients, we must accept the growing role of nurses in patient safety.
Pharma leaders, policy makers discuss COVID-19 impact, way forward for industry expresspharma
June 02, 2020
Most are optimistic about the future but accentuate the need for investments in technology and other strategic measures to ensure progress.
Biogenerics companies need to focus on robust and stringent clinical trials expresspharma
June 02, 2020
To capitalise on emerging opportunities, domestic producers must ready themselves with large-scale, comprehensive clinical programmes which prove the safety of their biogenerics and efficacy in the treatment of the disease they target.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 33 34 Next page